News Articles for Lee Rodne

Lee Rodne has resigned as managing director and chief executive officer of Admedus, effective 30 June 2016. Mr Rodne has been a part of the company since the past 10 years.

Biotech company Admedus has initiated a capital raising comprising a placement and rights issue, with the hope of generating up to $28 million to fund ongoing development of various health care programs.

WA biotechs are drowning in a sea of red as yet more negative results are reported.

Biotech company Admedus has completed an oversubscribed $8 million share placement as it looks to push marketing for its CardioCel regenerative tissue product in Europe and the US.

Admedus, formerly Allied Healthcare, has struck a deal to acquire a manufacturing site that pharmaceutical giant Sanofi built in Malaga in 2009.

Healthcare technology company Allied Healthcare Group will seek to raise $10 million as it looks to launch its CardioCel regenerative tissue patch in Europe.